Analytical Data
-
基因名
PHLDA1
- Application
-
别名
Apoptosis-associated nuclear protein Proline- and glutamine-rich protein PHRIP, TDAG51
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WV24
-
表达区间
1-401aa
-
分子量
50.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PHLDA1, or Pleckstrin Homology-like Domain, Family A, Member 1, is a protein that has garnered significant attention due to its potential implications in various biological processes and diseases. Originally identified as a gene involved in the regulation of cell growth and apoptosis, PHLDA1 is known to interact with several key signaling pathways, particularly those related to cancer development and progression. Recent studies have highlighted its role in the modulation of cell survival, differentiation, and stress response, suggesting that it may act as a tumor suppressor in certain contexts. Additionally, PHLDA1's expression levels have been associated with various cancers, such as breast and colorectal cancer, indicating its potential use as a biomarker for diagnosis and prognosis. The pursuit of recombinant PHLDA1 proteins aims to facilitate a deeper understanding of its structure-function relationships and physiological roles. Through expression systems, researchers can produce this protein in sufficient quantities for functional assays, structural studies, and therapeutic applications. Ultimately, the exploration of PHLDA1's contributions to cellular mechanisms may pave the way for targeted therapies and novel diagnostic tools in oncology. The ongoing investigation of PHLDA1's functional properties and its interactions with other cellular components is critical for unraveling its potential as a target in cancer treatment and improving our grasp of tumor biology. As such, PHLDA1 research embodies a promising avenue in contemporary biomedical science.
